Third blog in a series by Joy Lindsay, Managing Partner, Sofia Fund. View Blog I here and Blog II here.
In my first two blogs of this three-part series, I covered two very important attributes that the right investor for your business should be able to offer – business acumen in running a company in your industry, and help in structuring and executing your financing strategy.…
Second blog in a series by Joy Lindsay, Managing Partner, Sofia Fund. View Blog I here and Blog III here.
As a startup looking for capital, due diligence done by an entrepreneur is as important as due diligence done by the investor looking to invest in the business.…
Sofia Fund portfolio company CogRX has received a $16.6M Multi-Year Grant for Phase II studies of its Elayta™ drug for mild-to-moderate Alzheimer’s disease. Learn more at CogRX announces NIA grant…
First blog in a series by Joy Lindsay, Managing Partner, Sofia Fund. View Blog II here and Blog III here.
Follow the money, but find the fit. It’s advice I’ve been giving to entrepreneurs for more than 20 years.
The right investor can offer so much more to an entrepreneur and her business than simply cash.…
Minneapolis, MN, September 5, 2018 — Sofia Fund, a leading angel investment group focused on high-growth, women-led early stage companies, today announced its most recent investment in Kenzen, a San Francisco-based health analytics platform focused on predicting and preventing avoidable health conditions.…
Technology Company Vixar Acquired by Semiconductor Leader Osram
Minneapolis, MN, July 31, 2018 — Sofia Fund, a leading angel investment firm focused on high-growth women-led technology based early stage companies, today announced that its portfolio company, technology company Vixar Inc., has been acquired by Osram Semiconductor, a unit of Osram, a German-based lighting technology company.…
Interview with Neal St Anthony of the Star Tribune brings visibility to Sofia Fund and its partners’ long and successful involvement in investing in women led companies.
Sofia Fund Partners Maintain Their Focus on Women-Led Firms…
A recent post in the April/ May Issue of MIT Review discusses the science Uzma Samadani used as she sought to find a way to measure improvements in her severely, brain-injured patients. The ability to capture a large amount of data from tracking not only eye movement but restrictions on range of motion in the eye led to the EyeBox product being developed by Oculogica, one of Sofia Fund’s portfolio companies.…
Minneapolis, MN, May 3, 2018 — Sofia Fund, a leading angel investment firm focused on high-growth, women-led early stage companies, today announced it has invested in Joylux, Inc., the Seattle-based women’s intimate health and wellness company.
The Sofia Fund investment was part of Joylux’s recent Series A financing round, which closes Aug.…
Rebiotix, Inc., Announces Its Acquisition
Minneapolis, MN, April 9, 2018 — Sofia Fund, a leading angel investment firm focused on high-growth, women-led early stage companies, today announced that its portfolio company, Rebiotix, Inc., is being acquired by Ferring Holding, Inc.,…